Dermacyte AC Matrix Amniotic Membrane Allograft

Harnessing the potential of amnion-chorion allograft to protect tissue defects.

A Full Thickness Amnion-Chorion Allograft

Dermacyte AC Matrix Amniotic Membrane Allograft represents an innovative approach in protecting internal and external tissue defects.

DERMACYTE AC MATRIX AMNIOTIC MEMBRANE ALLOGRAFT is intended for use as a protective covering or barrier for repair/reconstruction of internal and external tissue defects.

Dermacyte^® AC Matrix Amniotic Membrane Allograft

Dermacyte® AC Matrix Amniotic Membrane Allograft includes both amnion and chorion membrane and is prepared by a proprietary process that includes cleaning, disinfection, rinsing, cutting, lyophilization, and sterilization using irradiation.

Based on proprietary advancements in amniotic tissue processing, Dermacyte AC Matrix Amniotic Membrane Allograft is created from amnion-chorion tissue that undergoes rigorous donor screening and utilizes a novel lyophilization method to achieve a shelf-stable product for convenient use in protecting internal and external tissue defects.

Dermacyte AC Matrix Amniotic Membrane Allograft excels in

Versatile:

Ease of use across various clinical settings as a lyophilized allograft.

Full Thickness:

Prepared with both amnion and chorion membrane.

Protective Barrier:

May be used to cover internal and external tissue defects.

Convenience:

Stable and uncomplicated 5 year shelf life.

Application and Usage of Dermacyte AC Matrix Amniotic Membrane Allograft

Dermacyte AC Matrix Amniotic Membrane Allograft provides a full thickness (amnion-chorion) allograft design for versatile usage and convenience.

Dermacyte AC Matrix Amniotic Membrane Allograft is intended for use as a protective covering or barrier for:

Download Product Brochure

Repair/reconstruction of internal tissue defects

Repair/reconstruction of external tissue defects

Use by a physician or other qualified healthcare professional

Single-patient use, on a single occasion only

photos of doctors operating and a family spending time together

Dermacyte AC Matrix Amniotic Membrane Specifications

Product Numbers	Identifier	Product Description
AC-L10022	MT20022	Lyophilized Amnion Chorion 2 x 2 cm
AC-L10023	MT20023	Lyophilized Amnion Chorion 2 x 3 cm
AC-L10033	MT20033	Lyophilized Amnion Chorion 3 x 3 cm
AC-L10044	MT20044	Lyophilized Amnion Chorion 4 x 4 cm
AC-L10046	MT20046	Lyophilized Amnion Chorion 4 x 6 cm
AC-L10059	MT20059	Lyophilized Amnion Chorion 5 x 9 cm
AC-L10066	MT20066	Lyophilized Amnion Chorion 6 x 6 cm
AC-L10068	MT20068	Lyophilized Amnion Chorion 6 x 8 cm
AC-L10077	MT20077	Lyophilized Amnion Chorion 7 x 7 cm
AC-L 10412	MT20412	Lyophilized Amnion Chorion 4 x 12 cm
AC-L10912	MT20912	Lyophilized Amnion Chorion 9 x 12 cm
AC-L10616	MT20616	Lyophilized Amnion Chorion 6 x 16 cm
AC-L 10816	MT20816	Lyophilized Amnion Chorion 8 x 16 cm
AC-L10920	MT20920	Lyophilized Amnion Chorion 9 x 20 cm

Photo of professionals chatting while walking

Reimbursement
and Support for Dermacyte AC Matrix Amniotic Membrane Allograft

Merakris offers a comprehensive reimbursement support for providers using Dermacyte AC Matrix. To start the insurance verification process, use this form:

Dermacyte AC Matrix Amniotic Membrane Allograft is regulated by the U.S. Food and Drug Administration (FDA) as a minimally manipulated human allograft tissue under its Human Cells, Tissues, and Tissue-Based Products (HCT/P) guidelines, subject to Section 361 of the Public Health Service Act and 21 CFR 1271.

Regulatory Compliance

Merakris Therapeutics is committed to being a best in class organization in the development and commercialization of healthcare technologies in order to provide customers the highest quality products that offer consistent safety and performance.

FDA registered and audited manufacturing facilities